Del Mar, CA, United States of America

Eric Martin

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Kinnate Biopharma Inc., Pierre Fabre Medicament. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Martin. Retrieved from https://idiyas.com/inventor/eric-martin-qxgr5wy3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Martin

Introduction

Eric Martin is a notable inventor based in Del Mar, California. He has made significant strides in the field of oncology through his innovative research and development efforts. His work primarily focuses on the treatment of cancer, showcasing his commitment to improving patient outcomes.

Latest Patents

Eric Martin holds a patent for the treatment of cancer with a RAF inhibitor. This patent outlines compositions and methods for treating cancer, which include a RAF inhibitor. Some embodiments of his invention feature combination therapy that incorporates the RAF inhibitor alongside at least one oncology therapeutic agent. This innovative approach has the potential to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout his career, Eric has demonstrated a strong dedication to advancing cancer treatment methodologies. His work at Kinnate Biopharma Inc. has positioned him as a key player in the pharmaceutical industry. His contributions are vital in the ongoing battle against cancer, reflecting his expertise and innovative spirit.

Collaborations

Eric collaborates with talented professionals in his field, including Aleksandra Franovic and Nichol L G Miller. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Eric Martin's contributions to cancer treatment through his patent and work at Kinnate Biopharma Inc. highlight his role as an influential inventor in the medical field. His innovative approaches continue to pave the way for advancements in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…